We are live on ! Find out more
SCLN

Sciclone Pharmaceuticals Inc
SCLN

Delisted

SCLN was delisted on the 13th of October, 2017.

Back to rankings

0 hedge funds and large institutions have $0 invested in Sciclone Pharmaceuticals Inc in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 128 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 129 → 0 (-129)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $394M → $0 (-$394M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 128

Holders
–
Holders Change
-129
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
128
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$82.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$33.3M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$32.3M
4
GP
GLG Partners
United Kingdom
-$29M
5
State Street
State Street
Massachusetts
-$18.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
YMRC
76
Yorktown Management & Research Company
Virginia
– -$423K -37,800 Closed
State Board of Administration of Florida Retirement System
77
State Board of Administration of Florida Retirement System
Florida
– -$414K -36,990 Closed
NFA
78
Nationwide Fund Advisors
Ohio
– -$414K -36,967 Closed
GF
79
Gabelli Funds
New York
– -$405K -36,187 Closed
KBC Group
80
KBC Group
Belgium
– -$383K -34,159 Closed
Public Sector Pension Investment Board (PSP Investments)
81
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
– -$365K -32,587 Closed
Thrivent Financial for Lutherans
82
Thrivent Financial for Lutherans
Minnesota
– -$356K -31,810 Closed
Balyasny Asset Management
83
Balyasny Asset Management
Illinois
– -$345K -30,800 Closed
FRM
84
Fox Run Management
Connecticut
– -$321K -28,700 Closed
New York State Teachers Retirement System (NYSTRS)
85
New York State Teachers Retirement System (NYSTRS)
New York
– -$312K -27,821 Closed
CGH
86
Crossmark Global Holdings
Texas
– -$311K -27,770 Closed
VOYA Investment Management
87
VOYA Investment Management
Georgia
– -$311K -27,747 Closed
DAM
88
DLD Asset Management
New York
– -$308K -27,500 Closed
ASRS
89
Arizona State Retirement System
Arizona
– -$304K -27,100 Closed
BNP Paribas Financial Markets
90
BNP Paribas Financial Markets
France
– -$303K -27,050 Closed
TI
91
Telemetry Investments
New York
– -$246K -22,000 Closed
UBS AM
92
UBS AM
Illinois
– -$241K -21,549 Closed
LSERS
93
Louisiana State Employees Retirement System
Louisiana
– -$237K -21,200 Closed
Public Employees Retirement Association of Colorado
94
Public Employees Retirement Association of Colorado
Colorado
– -$216K -19,307 Closed
SSP
95
Sapphire Star Partners
Washington
– -$209K -18,724 Closed
TRSOTSOK
96
Teachers Retirement System of the State of Kentucky
Kentucky
– -$199K -17,800 Closed
JMPWA
97
JP Morgan Private Wealth Advisors
California
– -$198K -17,670 Closed
FIM
98
Freedom Investment Management
Connecticut
– -$173K -15,437 Closed
Los Angeles Capital Management
99
Los Angeles Capital Management
California
– -$170K -15,175 Closed
KAM
100
Kassirer Asset Management
Ontario, Canada
– -$168K -15,000 Closed
2 3
4
5 6

SCLN Hedge Fund Activity: Q4 2017 in Review

0 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q4 2017, worth a combined $0 — down 100% from $394M a quarter earlier.

Sellers outnumbered buyers: 128 funds closed out of SCLN and 0 opened new positions — a net loss of 128 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $82.1M sold.

  • 0 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q4 2017, down from 129 in Q3 2017.
  • Funds reported $0 of Sciclone Pharmaceuticals Inc stock for Q4 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Sciclone Pharmaceuticals Inc positions in Q4 2017 and 128 closed out, a net change of -128 holders.
  • The largest Sciclone Pharmaceuticals Inc seller in Q4 2017 was BlackRock, an estimated $82.1M sold.

Based on aggregated 13F filings for Q4 2017.